Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding?

Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding?

The optimal antithrombotic strategy after percutaneous left atrial appendage closure (LAAC) has not yet been established. The advisability of administering low-dose direct oral anticoagulation after LAAC to patients at high risk of bleeding is uncertain. Thus, in the present study, we evaluated the...

Full description

Bibliographic Details
Main Authors: Xiao-Dong Zhou, Qin-Fen Chen, Fang Lin, Liangguo Wang, Yihe Chen, Dongjie Liang, Weijian Huang, Fangyi Xiao
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
atrial fibrillation
left atrial appendage closure
rivaroxaban
stroke
bleeding
device-related thrombosis
Online Access:https://www.mdpi.com/2077-0383/12/3/847

Internet

https://www.mdpi.com/2077-0383/12/3/847

Similar Items